ImmunoPrecise Antibodies (IPA) Misses Q4 EPS by 5c

ImmunoPrecise Antibodies (NASDAQ: IPA) reported Q4 EPS of ($0.05). Revenue for the quarter came in at $6.98 million.

For earnings history and earnings-related data on ImmunoPrecise Antibodies (IPA) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low